The effect of the first-generation HCV-protease inhibitors boceprevir and telaprevir and the relation to baseline NS3 resistance mutations in genotype 1: experience from a small Swedish cohort

DOI: 10.1080/03009734.2018.1441928

Keywords: Boceprevir, hepatitis C, protease inhibitor, RAS, resistance association substitution, telaprevir

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text